Literature DB >> 8088767

The gastric cardia in Helicobacter pylori infection.

R M Genta1, R M Huberman, D Y Graham.   

Abstract

Helicobacter pylori gastritis is believed to be both more prevalent and more severe in the antrum than in the corpus. The mucosa of the cardia is architecturally similar to that of the antrum. This study was designed to test the hypothesis that intensity of H pylori infection and the associated inflammation are similar in the cardia and the antrum and are greater in these locations than in the corpus. A total of 445 gastric biopsy specimens were obtained from predetermined sites from 50 subjects (42 with demonstrated H pylori infection). Slides were stained with a combined stain to simultaneously visualize H pylori, mucosal morphology, and inflammatory infiltrate. Numbers of H pylori, inflammatory responses, and intestinal metaplasia were graded on a scale from 0 to 5. Helicobacter pylori was detected in the cardia of 40 of the 42 infected subjects (95%). Helicobacter pylori density was similar in the three gastric regions. The intensity of chronic active gastritis was similar in the antrum and the cardia, and was higher in these locations than in the corpus (P < .005). Lymphoid follicles were significantly less prevalent in the cardia and in the corpus than in the antrum (P < .05). Helicobacter pylori infection was as prevalent in the cardia as in the rest of the stomach and its density was similar in all sites of antrum, corpus, and cardia. The inflammatory responses characteristic of chronic active gastritis, except for lymphoid follicles, were similar in the antrum and the cardia and in both these locations were more intense than in the corpus. The significance of these findings is discussed with respect to the relationship between H pylori infection and the genesis of gastric adenocarcinoma and lymphoma.

Entities:  

Mesh:

Year:  1994        PMID: 8088767     DOI: 10.1016/0046-8177(94)90011-6

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  32 in total

Review 1.  Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation.

Authors:  D McNamara; C O'Morain
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

2.  The phenotype of gastric mucosa coexisting with Barrett's oesophagus.

Authors:  M Rugge; V Russo; G Busatto; R M Genta; F Di Mario; F Farinati; D Y Graham
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

Review 3.  New approaches to Helicobacter pylori infection in children.

Authors:  B D Gold
Journal:  Curr Gastroenterol Rep       Date:  2001-06

4.  CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer.

Authors:  M Kudo; O Gutierrez; H M T El-Zimaity; H Cardona; Z Z Nurgalieva; J Wu; D Y Graham
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

5.  Helicobacter pylori extract induces nuclear factor-kappa B, activator protein-1, and cyclooxygenase-2 in esophageal epithelial cells.

Authors:  Mohamed M M Abdel-Latif; Henry Windle; Ana Terres; Déirdre Ní Eidhin; Dermot Kelleher; John V Reynolds
Journal:  J Gastrointest Surg       Date:  2006-04       Impact factor: 3.452

Review 6.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 7.  Barrett's oesophagus: from metaplasia to dysplasia and cancer.

Authors:  J-F Fléjou
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 8.  Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?

Authors:  J Labenz; P Malfertheiner
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

9.  Use of PCR and culture to detect Helicobacter pylori in naturally infected cats following triple antimicrobial therapy.

Authors:  S E Perkins; L L Yan; Z Shen; A Hayward; J C Murphy; J G Fox
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

10.  Helicobacter pylori requires TlpD-driven chemotaxis to proliferate in the antrum.

Authors:  Annah S Rolig; James Shanks; J Elliot Carter; Karen M Ottemann
Journal:  Infect Immun       Date:  2012-07-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.